Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chronic Condition OTCs Safety Questioned By Consumers - CHPA Survey

This article was originally published in The Tan Sheet

Executive Summary

U.S. consumers express ambivalence when it comes to treating chronic conditions with OTC medications, according to a survey released by the Consumer Healthcare Products Association March 21.

You may also be interested in...



Supplement Safety, Content Oversight Deemed Inadequate By 60% In Surveys

Government regulation of dietary supplement safety is considered insufficient by nearly 60% of combined participants in several national surveys, researchers report in the March 26 Archives of Internal Medicine.

Supplement Safety, Content Oversight Deemed Inadequate By 60% In Surveys

Government regulation of dietary supplement safety is considered insufficient by nearly 60% of combined participants in several national surveys, researchers report in the March 26 Archives of Internal Medicine.

Supplement Safety, Content Oversight Deemed Inadequate By 60% In Surveys

Government regulation of dietary supplement safety is considered insufficient by nearly 60% of combined participants in several national surveys, researchers report in the March 26 Archives of Internal Medicine.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel